Related Articles
Growth arrest by activated BRAF and MEK inhibition in human anaplastic thyroid cancer cells
Potential synergistic effects of sorafenib and CP‑31398 for treating anaplastic thyroid cancer with p53 mutations
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
Antitumor activity of Pulsatilla koreana extract in anaplastic thyroid cancer via apoptosis and anti-angiogenesis
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo